PlainRecalls
FDA Drug Critical Class I Ongoing

Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10

Reported: May 31, 2017 Initiated: April 21, 2017 #D-0862-2017

Product Description

Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10

Reason for Recall

Presence of Particulate Matter: human hair found within an internal sample syringe.

Details

Recalling Firm
Hospira Inc.
Units Affected
71,550 syringes
Distribution
Nationwide in the USA and Puerto Rico
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10. Recalled by Hospira Inc.. Units affected: 71,550 syringes.
Why was this product recalled?
Presence of Particulate Matter: human hair found within an internal sample syringe.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 31, 2017. Severity: Critical. Recall number: D-0862-2017.